多重利好加身心玮医疗大涨14%

动脉网01-21

心玮医疗-B股价早盘大涨14%至57.85港元，主要受多重利好消息推动。公司预计2025年度收益将达4亿至4.1亿元人民币，较2024年增长至少43.9%，并实现除税前利润约8000万元，较2024年的净亏损1200万元有显著改善。此外，公司开发的自膨式颅内药物洗脱支架已获国家药品监督管理局受理注册申请，该产品用于治疗颅内动脉粥样硬化性狭窄，具有支撑和开通管腔、预防再狭窄的作用。目前全球尚无类似...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2605171270?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-01-21 14:55","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2605171270","market":"hk","top_or_hot":-1,"title":"多重利好加身心玮医疗大涨14%","media":"动脉网","content":"<div>\n<p>心玮医疗-B股价早盘大涨14%至57.85港元，主要受多重利好消息推动。公司预计2025年度收益将达4亿至4.1亿元人民币，较2024年增长至少43.9%，并实现除税前利润约8000万元，较2024年的净亏损1200万元有显著改善。此外，公司开发的自膨式颅内药物洗脱支架已获国家药品监督管理局受理注册申请，该产品用于治疗颅内动脉粥样硬化性狭窄，具有支撑和开通管腔、预防再狭窄的作用。目前全球尚无类似...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260121145718a4446963&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>多重利好加身心玮医疗大涨14%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n多重利好加身心玮医疗大涨14%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-01-21 14:55 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260121145718a4446963&s=b><strong>动脉网</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>心玮医疗-B股价早盘大涨14%至57.85港元，主要受多重利好消息推动。公司预计2025年度收益将达4亿至4.1亿元人民币，较2024年增长至少43.9%，并实现除税前利润约8000万元，较2024年的净亏损1200万元有显著改善。此外，公司开发的自膨式颅内药物洗脱支架已获国家药品监督管理局受理注册申请，该产品用于治疗颅内动脉粥样硬化性狭窄，具有支撑和开通管腔、预防再狭窄的作用。目前全球尚无类似...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260121145718a4446963&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06609","symbol_name":"心玮医疗-B","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260121145718a4446963&s=b","article_id":"2605171270","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260121145718a4446963&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2605171270","pubTimestamp":1768978500,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"心玮医疗-B股价早盘大涨14%至57.85港元，主要受多重利好消息推动。公司预计2025年度收益将达4亿至4.1亿元人民币，较2024年增长至少43.9%，并实现除税前利润约8000万元，较2024年的净亏损1200万元有显著改善。此外，公司开发的自膨式颅内药物洗脱支架已获国家药品监督管理局受理注册申请，该产品用于治疗颅内动脉粥样硬化性狭窄，具有支撑和开通管腔、预防再狭窄的作用。目前全球尚无类似产品获批上市，公司在该领域的研发进度处于行业领先地位。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"06609":"心玮医疗-B","BK1574":"生物医药B类股","BK1100":"医疗保健设备","BK1587":"次新股"},"translate_title":"Multiple benefits plus body and mind Wei Medical rose 14%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06609":1.5},"content_text":"心玮医疗-B股价早盘大涨14%至57.85港元，主要受多重利好消息推动。公司预计2025年度收益将达4亿至4.1亿元人民币，较2024年增长至少43.9%，并实现除税前利润约8000万元，较2024年的净亏损1200万元有显著改善。此外，公司开发的自膨式颅内药物洗脱支架已获国家药品监督管理局受理注册申请，该产品用于治疗颅内动脉粥样硬化性狭窄，具有支撑和开通管腔、预防再狭窄的作用。目前全球尚无类似产品获批上市，公司在该领域的研发进度处于行业领先地位。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2605171270","isCrawlerRequest":true}